COL3-03 Bactériémies à SARM (BSARM) : comment optimiser le traitement antibiotique ?
E. Forestier(Hôpitaux Universitaires de Strasbourg), Y. Hansmann(Hôpitaux Universitaires de Strasbourg), G. Camuset, D. Christmann, Nicolas Lefèbvre(Hôpital Civil, Strasbourg), F. Jehl
Cited by 0
Related Papers
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020
|Eurosurveillance|2020|129
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
|EBioMedicine|2020|113
Risk factors for death among tuberculosis cases: analysis of European surveillance data
|European Respiratory Journal|2008|99
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients
|Clinical Microbiology and Infection|2020|84